홈 › 폐암 › 사우스캐롤라이나

사우스캐롤라이나의 폐암 임상 시험

폐암 관련 연구 19개가 사우스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.

사우스캐롤라이나의 도시

공식 연구 텍스트(영어)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Bon Secours Saint Francis Hospital, Charleston
외 15개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Ralph H Johnson VA Medical Center, Charleston
Medical University of South Carolina, Charleston

피험자 모집 중3상

70세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06096844

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Gibbs Cancer Center-Gaffney, Gaffney
외 9개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06498635

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Medical University of South Carolina, Florence
Medical University of South Carolina Health Lancaster Medical Center, Lancaster

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05920356

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Saint Joseph's Candler Health System ( Site 4010), Bluffton
Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312137

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0608, Greenville

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07063745

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Medical University of South Carolina, Charleston
Prisma Health Cancer Institute, Greenville
Lexington Medical Center, West Columbia

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
외 11개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Health Education Approach to Lung Screening

Medical University of South Carolina, Charleston

피험자 모집 중건강한 지원자 환영

50세 ~ 80세 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06070870

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Saint Joseph's/Candler - Bluffton Campus, Bluffton
Gibbs Cancer Center-Gaffney, Gaffney
Saint Francis Hospital, Greenville
외 8개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05624996

Prediction Augmented Screening Initiative

Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston

피험자 모집 중

50세 ~ 80세 · 모든 성별 · 2026. 6. 26. 업데이트됨 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

AnMed Health Cancer Center, Anderson
Saint Joseph's/Candler - Bluffton Campus, Bluffton
Prisma Health Cancer Institute - Spartanburg, Boiling Springs
외 9개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

AnMed Health Cancer Center, Anderson
Saint Joseph's/Candler - Bluffton Campus, Bluffton
Medical University of South Carolina, Charleston
외 5개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

AnMed Health Cancer Center, Anderson

피험자 모집 중2상

18 Minutes · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT06031688

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Medical University of South Carolina, Charleston
McLeod Health, Florence

피험자 모집 중관찰 연구건강한 지원자 환영

40세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

AnMed Health Cancer Center, Anderson
Saint Joseph's/Candler - Bluffton Campus, Bluffton
Gibbs Cancer Center-Gaffney, Gaffney
외 7개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 1. 9. 업데이트됨 · NCT06073431

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Greenville

피험자 모집 중관찰 연구

전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Medical University of South Carolina (MUSC), Charleston
McLeod Health, Florence

피험자 모집 중관찰 연구

50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Ralph H. Johnson VA Health Care System, Charleston

피험자 모집 중관찰 연구

29세 ~ 85세 · 모든 성별 · 2024. 11. 13. 업데이트됨 · NCT06426628

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.